2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Balance assessment and effect of virtual reality in Hereditary Spastic Paraplegia

M. Severiano, G. Dos Santos, C. de Araújo, F. Gonçalves, B. Zeigelboim, H. Teive (Curitiba, Brazil)
Balance biomarker for early differentiation of Parkinson’s disease and multiple system atrophy with parkinsonian type

HJ. Chang, JH. Kim, S. Lee, E. Kwon, SH. Jeong, E. Oh (Daejeon, Republic of Korea)
Balance confidence may not accurately assess fall risk in atypical parkinsonism

G. Arleth, E. Buxton, R. Bryant, M. Ivancic, N. Browner, J. Shurer, M. Sklerov (Chapel Hill, USA)
Barriers and Facilitators of Adherence to Mediterranean-Ketogenic and MCT-Supplemented Mediterranean Diets in Parkinson’s Disease: A Qualitative Secondary Analysis from a Random-Order Crossover Trial

K. Tosefsky, Y. Wang, J. Lam, A. Kuan, S. Appel-Cresswell (Vancouver, Canada)
Barriers to Healthcare Utilization and Adherence to Medications among People Living with Parkinson’s Disease in Senegal

M. Njohjam, M. Fall, F. Niakam, J. Kahwagi, A. Diop, M. N, A. Diop (Dakar, Senegal)
Barriers To Physical Exercise Adherence In Individuals With Parkinson’s Disease: A Cross-Sectional Study

S. Souza, G. Leveck, T. Christinelli, L. Paladini, V. Israel (Curitiba, Brazil)
Basal Ganglia Neurophysiological Activity Associated with Depression in Parkinson’s Disease

K. Johnson, P. Coutinho, L. Kenney, J. Wong, J. Hilliard, K. Foote, D. Bowers, G. Pontone, C. de Hemptinne (Gainesvile, USA)
Basal Ganglia Physiomarkers of Non-motor Symptoms in Parkinson’s Disease: a Systematic Review

B. Keulen, M. Beudel, A. Malekzadeh, R. de Bie, B. Swinnen (Amsterdam, Netherlands)
Baseline brain inflammation is associated with less cognitive progression at 24 months in subjects with de novo Parkinson’s disease

T. Yacoubian, N. Stover, M. Dean, A. Amara, L. Ruffrage, H. Qin, E. Benveniste, Y. Fang, J. Mcconathy, Y. Zhang, R. Kennedy, A. Gerstenecker, D. Standaert (Birmingham, USA)
Baseline cerebrospinal levels of p-tau and amyloid beta and striatal dopamine transporter binding predict mild cognitive impairment and dementia diagnosis in Parkinson’s disease

L. Collins-Praino, A. Mcnamara, I. Baetu (Adelaide, Australia)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z